A bacterial effector targets host DH‐PH domain RhoGEFs and antagonizes macrophage phagocytosis
暂无分享,去创建一个
F. Shao | Liping Liu | Na Dong
[1] M. Ding,et al. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. , 2009, Molecular cell.
[2] J. Chai,et al. Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics , 2009, Nature Structural &Molecular Biology.
[3] N. Huang,et al. A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle , 2009, Proceedings of the National Academy of Sciences.
[4] B. Kenny,et al. The effector repertoire of enteropathogenic E. coli: ganging up on the host cell , 2009, Current opinion in microbiology.
[5] M. Jepson,et al. The mechanisms used by enteropathogenic Escherichia coli to control filopodia dynamics , 2008, Cellular microbiology.
[6] Hongtao Li,et al. Structure of a Shigella effector reveals a new class of ubiquitin ligases , 2008, Nature Structural &Molecular Biology.
[7] Samuel I. Miller,et al. Structure and function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family GTPases induce endosomal tubulation. , 2008, Cell host & microbe.
[8] Irene C. Blat,et al. MLK3 limits activated Galphaq signaling to Rho by binding to p63RhoGEF. , 2008, Molecular cell.
[9] Hui-Chun Cheng,et al. Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspFU , 2008, Nature.
[10] Wendell A. Lim,et al. The pathogen protein EspFU hijacks actin polymerization using mimicry and multivalency , 2008, Nature.
[11] E. Caron,et al. EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis , 2008, Cellular microbiology.
[12] G. Frankel,et al. Attaching effacing Escherichia coli and paradigms of Tir‐triggered actin polymerization: getting off the pedestal , 2008, Cellular microbiology.
[13] R. Neubig,et al. Structure of Gαq-p63RhoGEF-RhoA Complex Reveals a Pathway for the Activation of RhoA by GPCRs , 2007, Science.
[14] C. Sasakawa,et al. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. , 2007, Cell host & microbe.
[15] J. Dixon,et al. Interactions of bacterial effector proteins with host proteins. , 2007, Current opinion in immunology.
[16] Hans Wolf-Watz,et al. Identification of a molecular target for the Yersinia protein kinase A. , 2007, Molecular cell.
[17] C. Der,et al. Auto-inhibition of the Dbl Family Protein Tim by an N-terminal Helical Motif* , 2007, Journal of Biological Chemistry.
[18] She Chen,et al. The Phosphothreonine Lyase Activity of a Bacterial Type III Effector Family , 2007, Science.
[19] Hans Wolf-Watz,et al. Protein delivery into eukaryotic cells by type III secretion machines , 2006, Nature.
[20] B. Kenny,et al. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI‐3 kinase‐mediated uptake independently of mitochondrial targeting , 2006, Cellular microbiology.
[21] M. Donnenberg,et al. Analysis of the Function of Enteropathogenic Escherichia coli EspB by Random Mutagenesis , 2006, Infection and Immunity.
[22] E. Caron,et al. Subversion of actin dynamics by EPEC and EHEC. , 2006, Current opinion in microbiology.
[23] W. Dietrich,et al. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin , 2006, Nature Genetics.
[24] T. Hughes,et al. Identification of a Bacterial Type III Effector Family with G Protein Mimicry Functions , 2006, Cell.
[25] G. Frankel,et al. Enteropathogenic and Enterohemorrhagic Escherichia coli Infections: Translocation, Translocation, Translocation , 2005, Infection and Immunity.
[26] Klaus Aktories,et al. Bacterial cytotoxins: targeting eukaryotic switches , 2005, Nature Reviews Microbiology.
[27] M. Waldor,et al. The Locus of Enterocyte Effacement-Encoded Effector Proteins All Promote Enterohemorrhagic Escherichia coli Pathogenicity in Infant Rabbits , 2005, Infection and Immunity.
[28] É. Oswald,et al. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin‐cytoskeleton † , 2004, Cellular microbiology.
[29] J. Otlewski,et al. The crystal structure of RhoA in complex with the DH/PH fragment of PDZRhoGEF, an activator of the Ca(2+) sensitization pathway in smooth muscle. , 2004, Structure.
[30] J. Leong,et al. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. , 2004, Developmental cell.
[31] S. Clare,et al. Identification of a Novel Citrobacter rodentium Type III Secreted Protein, EspI, and Roles of This and Other Secreted Proteins in Infection , 2004, Infection and Immunity.
[32] T. Pawson,et al. Dissecting virulence: systematic and functional analyses of a pathogenicity island. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[33] Harry L. T. Mobley,et al. Pathogenic Escherichia coli , 2004, Nature Reviews Microbiology.
[34] Jack E. Dixon,et al. Cleavage of Arabidopsis PBS1 by a Bacterial Type III Effector , 2003, Science.
[35] X. Tu,et al. EspH, a new cytoskeleton‐modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli , 2003, Molecular microbiology.
[36] J. Dixon,et al. A Yersinia Effector and a Pseudomonas Avirulence Protein Define a Family of Cysteine Proteases Functioning in Bacterial Pathogenesis , 2002, Cell.
[37] B. Kenny,et al. Co‐ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules , 2002, Molecular microbiology.
[38] A. Hall,et al. Vav regulates activation of Rac but not Cdc42 during FcγR-mediated phagocytosis , 2002 .
[39] B. Finlay,et al. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3‐kinase‐dependent pathways , 2001, The EMBO journal.
[40] Xin-Yun Huang,et al. Structural Basis for Relief of Autoinhibition of the Dbl Homology Domain of Proto-Oncogene Vav by Tyrosine Phosphorylation , 2000, Cell.
[41] M. Caligiuri,et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Hedberg,et al. Food-related illness and death in the United States. , 1999, Emerging infectious diseases.
[43] Takayuki Kato,et al. Cooperation between mDia1 and ROCK in Rho-induced actin reorganization , 1999, Nature Cell Biology.
[44] J. Gutkind,et al. A Novel PDZ Domain Containing Guanine Nucleotide Exchange Factor Links Heterotrimeric G Proteins to Rho* , 1999, The Journal of Biological Chemistry.
[45] A. Hall,et al. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. , 1998, Science.
[46] J. Mao,et al. Guanine nucleotide exchange factor GEF115 specifically mediates activation of Rho and serum response factor by the G protein alpha subunit Galpha13. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[47] P C Sternweis,et al. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. , 1998, Science.
[48] A. Gilman,et al. p115 RhoGEF, a GTPase activating protein for Gα12 and Gα13 , 1998 .
[49] K. Hahn,et al. Agents That Inhibit Rho, Rac, and Cdc42 Do Not Block Formation of Actin Pedestals in HeLa Cells Infected with Enteropathogenic Escherichia coli , 1998, Infection and Immunity.
[50] A. Hall,et al. Rho GTPases and the actin cytoskeleton. , 1998, Science.
[51] B. Finlay,et al. Enteropathogenic E. coli (EPEC) Transfers Its Receptor for Intimate Adherence into Mammalian Cells , 1997, Cell.
[52] M. Mann,et al. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1 , 1997, Nature.
[53] C. Fiorentini,et al. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine , 1997, Nature.
[54] K. Fujisawa,et al. p160ROCK, a Rho‐associated coiled‐coil forming protein kinase, works downstream of Rho and induces focal adhesions , 1997, FEBS letters.
[55] G. Bollag,et al. Identification of a Novel Guanine Nucleotide Exchange Factor for the Rho GTPase* , 1996, The Journal of Biological Chemistry.
[56] William Clevenger,et al. Cloning and Characterization of an Alternatively Processed Human Type II Interleukin-1 Receptor mRNA* , 1996, The Journal of Biological Chemistry.
[57] R. Treisman,et al. The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF , 1995, Cell.
[58] J. Kaper,et al. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector , 1991, Infection and immunity.
[59] G. Donelli,et al. Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections , 1987, Journal of clinical microbiology.
[60] G. Frankel,et al. Enteropathogenic Escherichia coli: unravelling pathogenesis. , 2005, FEMS microbiology reviews.
[61] A. Hall,et al. Vav regulates activation of Rac but not Cdc42 during FcgammaR-mediated phagocytosis. , 2002, Molecular biology of the cell.
[62] M. Schwartz,et al. Determination of GTP loading on Rho. , 2000, Methods in enzymology.
[63] B. Finlay,et al. Enteropathogenic Escherichia coli inhibits phagocytosis. , 1999, Infection and immunity.